Showing posts with label Paxlovid. Show all posts
Showing posts with label Paxlovid. Show all posts

Paxlovid

Pfizer recently began Phase 2 and 3 trials in children and. Nirmatrelvir is an orally bioavailable protease inhibitor that is act…